论文部分内容阅读
糖尿病肾病是一种肾脏损伤和心血管疾病的风险增加的临床综合征，其危险因素主要有性别、遗传因素、肾血流动力学和糖尿病发病年龄。微量白蛋白尿是肾脏损害的早期临床检测标志。目前还没有能治愈糖尿病肾病的方法，姑息性治疗策略包括控制血糖、血压和尿蛋白。在高级阶段患者接受肾替代疗法，包括血液透析和肾移植。然而，肾源有限，治疗费用昂贵，限制了肾移植疗法的应用。随着肾功能进一步的恶化，肾衰竭严重，导致患者病死率增加。“,”Diabetic nephropathy is a syndrome of kidney damage with increased risk of cardiovascular disease.The major risk factors of the disease include gender,genetic factors,renal hemodynamics and diabe-tes onset age,etc.Microalbuminuria is a clinical testing sign of early kidney damage .There is currently no treatment method to cure diabetic nephropathy patients,palliative treatment strategies include medications to control the levels of blood glucose,blood pressure and urine protein.In advanced stage,patients accepted renal replacement therapy,including hemodialysis and renal transplantation .Unfortunately,renal source is so limited and expensive,which limits the kidney transplantation therapy .Therefore,as the renal functions of the patients further aggravate,renal failure will exacerbate and leads to an increased mortality rate.